Data / Medical devices / Italy / Sentinel CH. SPA
Sentinel CH. SPA: FDA-registered device maker in Milano, Italy, 24 510(k) clearances
Sentinel CH. SPA is registered with the FDA (registration 9681753) in Milano, Italy. It lists 27 device types. The FDA files 24 510(k) clearances under its listings, the newest dated May 16, 2025. 6 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 9681753
- FEI number
- 3000303338
- Address
- Via Robert Koch, 2, Milano, Italy, 20152
- Owner or operator
- SENTINEL CH. SpA (9025279)
- Roles
- Contract manufacturer, Manufacturer, Repackager or relabeler
- First device listed
- November 17, 2005
- Registered through
- 2026
- Brand names listed
- ACE Calibrator, ACE Control, ACE Control Set, ACE Liquid, ACE Reagent, AMMONIA CONTROLS, AMMONIA ULTRA, ARCHITECT c ACE Assay File and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| May 16, 2025 | K242585 | Cystatin C | NDY | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| December 22, 2022 | K211058 | Lp(a) Ultra | DFC | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| December 19, 2019 | K193001 | Albumin BCP | CJW | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| November 8, 2019 | K192118 | CRP Vario | DCK | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| September 27, 2018 | K173833 | CRP Vario | NQD | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| July 28, 2014 | K141728 | ACE CALIBRATOR | JIT | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| August 19, 2011 | K102706 | CKMB UDR ASSAY | JHS | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| September 3, 2009 | K083602 | KAPPA LIGHT CHAINS | DFH | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| June 22, 2009 | K083601 | LAMBDA LIGHT CHAINS | DEH | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| June 25, 2008 | K081533 | SENTINEL PLASMAPROTEINS CAL 3X | JIX | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| June 19, 2008 | K073634 | MULTIGENT CREATININE (ENZYMATIC) ASSAY | JFY | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| August 2, 2007 | K070987 | SENTINEL LITHIUM ASSAY | NDW | Substantially Equivalent | SENTINEL CH. SpA | accessdata.fda.gov |
| May 23, 2007 | K070971 | MODIFICATION TO SENTINEL CLIN CHEM CAL | JIX | Substantially Equivalent | Sentinel Ch. Srl | accessdata.fda.gov |
| January 26, 2006 | K051447 | SENTINEL PANCREATIC AMYLASE | JFJ | Substantially Equivalent | Sentinel Ch. Srl | accessdata.fda.gov |
| November 25, 2005 | K051114 | SENTINEL AMMONIA ULTRA DIAGNOSTIC ASSAY | JIF | Substantially Equivalent | Sentinel Ch. Srl | accessdata.fda.gov |
| November 17, 2005 | K051111 | SENTINEL UIBC LIQUID | JQF | Substantially Equivalent | Sentinel Ch. Srl | accessdata.fda.gov |
| October 21, 2005 | K051456 | SENTINEL CERULOPLASMIN | JFR | Substantially Equivalent | Sentinel Ch. Srl | accessdata.fda.gov |
| August 25, 2005 | K051115 | SENTINEL IRON LIQUID | JIY | Substantially Equivalent | Sentinel Ch. Srl | accessdata.fda.gov |
| August 8, 2005 | K050836 | CRP DIAGNOSTIC ASSAY | DCK | Substantially Equivalent | Sentinel Ch. Srl | accessdata.fda.gov |
| July 25, 2005 | K051457 | SENTINEL PLASMAPROTEINS CAL 3X | JIX | Substantially Equivalent | Sentinel Ch. Srl | accessdata.fda.gov |
| November 20, 2003 | K033501 | MODIFICATION TO CALIBRATOR FOR AUTOMATIC SYSTEMS (CFAS) | JIX | Substantially Equivalent | Roche Diagnostics Corp. | accessdata.fda.gov |
| July 6, 1998 | K981800 | SENTINEL CHOLINESTERASE LIQUID MODEL NUMBER 17.019A & 17.606 | HIH | Substantially Equivalent | Equal Diagnostics, Inc. | accessdata.fda.gov |
| July 19, 1996 | K961179 | SENTINEL LIPASE LIQUID MODEL 17.401B | CHI | Substantially Equivalent | Equal Diagnostics, Inc. | accessdata.fda.gov |
| April 20, 1994 | K940272 | ACS NORMAL ANGIOTENSIN CONVERTING ENZYME CONTROL | JJX | Substantially Equivalent | Analytical Control Systems, Inc. | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| September 29, 2023 | 93298 | Class II | Ongoing | IRON assay, Reference Numbers 6K95-41 and 6K95-30 | A high recovery of Iron assay has been observed at some customer sites. Internal studies confirmed the positive shift of Quality Control and patient samples results, up to 15% for Iron Products (Alinity c Iron Reagent REF. 08P3920) to be used on Abbott Alinity Instrument and to 30% for Iron Products (IRON REF. 6K95-41 and IRON REF. 6K95- 30) to be used on Ab | accessdata.fda.gov |
| July 29, 2021 | 88680 | Class III | Terminated | Alinity c CRP Vario Cardiac High Sensitivity Calibrator Kit (ref 07P5605) - Product Usage: use in the calibration of the Alinity c CRP Vario assay, Cardiac CRP high sensitivity method [Cardiac CRP], on the Alinity c anal | Calibrator vials were incorrectly labeled. Use of incorrectly labeled vials will cause the instrument to generate a warning that calibrators are incorrectly loaded and calibration will not be completed successfully. | accessdata.fda.gov |
| April 30, 2021 | 88040 | Class III | Ongoing | ACE Control Set - IVD Control set for the quantitative determination of Angiotensin Converting Enzyme (ACE) REF 1667001 | Claim for stability after reconstitution from lyophilized to liquid form does not meet the requirements. New IFU instructions for handling the product provided to end users. | accessdata.fda.gov |
| June 28, 2019 | 83516 | Class II | Terminated | MULTIGENT Lithium-intended for the quantitation of lithium in serum or plasma using respectively the ARCHITECT c Systems and the Alinity c analyzer List Number: 8L25-30 | Added an additional SmartWash parameter for the Lithium and Alinity c Lithium Reagent Kit, catalogue number 8L25-30 and 08P5320 to prevent the potential for carryover from the ARCHITECT Lactate Dehydrogenase (LDH) reagent (LN 2P56) may result infalsely elevated lithium patient results | accessdata.fda.gov |
| May 22, 2017 | 77405 | Class II | Terminated | MULTIGENT Creatinine (Enzymatic), Catalog Numbers 8L24-31 and 8L24-41; IVD. Intended for the quantitative determination of creatinine in human serum, plasma, and urine using the ARCHITECT c Systems The product is a medic | Reagent 1 component may result in Quality Control values shifting out of acceptable range, which is not resolved by recalibration. | accessdata.fda.gov |
| September 22, 2015 | 72311 | Class II | Terminated | Sentinel MULTIGENT Ammonia Ultra Reagent, In-Vitro Diagnostic for ammonia measurement; List Number: LN 6K89-30. Intended for the in vitro quantitative determination of Ammonia (NH3) in human plasma. | Results for ammonia are below the linear range of the assay for samples that have been collected in sodium or lithium heparin tubes. | accessdata.fda.gov |
Compare with other makers
- All makers of Assay, Porphyrin, Spectrophotometry, Lithium
- All makers of Calibrator, Multi-Analyte Mixture
- All makers of Single (Specified) Analyte Controls (Assayed And Unassayed)
- All makers of C-Reactive Protein, Antigen, Antiserum, And Control
Updated May 16, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.